share_log

Jiangsu Huachang Chemical's (SZSE:002274) Earnings Have Declined Over Three Years, Contributing to Shareholders 25% Loss

Jiangsu Huachang Chemical's (SZSE:002274) Earnings Have Declined Over Three Years, Contributing to Shareholders 25% Loss

華昌化工(SZSE:002274)的盈利已連續三年下降,導致股東損失25%
Simply Wall St ·  2024/10/25 07:30

While not a mind-blowing move, it is good to see that the Jiangsu Huachang Chemical Co., Ltd (SZSE:002274) share price has gained 19% in the last three months. But that doesn't change the fact that the returns over the last three years have been less than pleasing. After all, the share price is down 33% in the last three years, significantly under-performing the market.

雖然這不是一個令人震撼的舉動,但看到華昌化工(SZSE:002274)的股價在過去三個月上漲了19%還是令人高興的。但這並沒有改變過去三年回報表現不佳的事實。畢竟,過去三年股價下跌了33%,顯著低於市場表現。

Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline.

儘管過去一週對股東來說更令人放心,但在過去的三年中,他們仍然處於虧損狀態,因此讓我們看看基本業務是否對下降負責。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

不可否認的是,市場有時是高效的,但價格並不總是反映潛在的商業表現。一個不完美但簡單的方法來考慮公司市場感知如何改變是比較每股收益(EPS)變化和股價變動。

During the three years that the share price fell, Jiangsu Huachang Chemical's earnings per share (EPS) dropped by 7.1% each year. The share price decline of 13% is actually steeper than the EPS slippage. So it seems the market was too confident about the business, in the past. The less favorable sentiment is reflected in its current P/E ratio of 9.01.

在股價下跌的三年中,華昌化工的每股收益(EPS)每年下降了7.1%。股價下跌了13%,實際上比每股收益的下降幅度還要大。所以似乎市場對該業務在過去過於樂觀。目前的市盈率爲9.01,反映出不太有利的市場情緒。

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

您可以在下面的圖片中查看每股收益如何隨時間變化(單擊圖表以查看確切的價值)。

big
SZSE:002274 Earnings Per Share Growth October 24th 2024
深圳證券交易所:002274 每股收益增長 2024年10月24日

It might be well worthwhile taking a look at our free report on Jiangsu Huachang Chemical's earnings, revenue and cash flow.

值得一看我們的免費報告,關於華昌化工的收益、營業收入和現金流。

What About Dividends?

關於分紅派息的問題

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Jiangsu Huachang Chemical, it has a TSR of -25% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

考慮總股東回報以及股票價格回報對任何給定股票都是重要的。股票價格回報只反映了股價的變化,而總股東回報包含了分紅的價值(假設已再投資)和任何折價融資或分拆的好處。可以說,總股東回報提供了更全面的關於股票所產生回報的圖景。對於華昌化工來說,過去3年的總股東回報爲-25%。這個回報超過了我們之前提到的股價回報。這主要是由於它的分紅支付!

A Different Perspective

另一種看法

It's nice to see that Jiangsu Huachang Chemical shareholders have received a total shareholder return of 22% over the last year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 7% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with Jiangsu Huachang Chemical .

很高興看到華昌化工的股東在過去一年中獲得了22%的總股東回報。而且這包括了分紅。由於一年的總股東回報優於五年的總股東回報(後者爲每年7%),這似乎表明股票的表現最近有所改善。在最好的情況下,這可能暗示着一些真正的業務動能,意味着現在可能是深入研究的好時機。雖然考慮市場條件對股價的不同影響是非常值得的,但還有其他因素更爲重要。爲此,您應該知道我們發現的華昌化工的1個警告信號。

If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.

如果您和我一樣,那麼您一定不想錯過這份免費的被內部人員買入的低估小盤股清單。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文中引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論